GEODE CAPITAL MANAGEMENT, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 16 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$380,000
-96.5%
550,000
-96.4%
0.00%
-100.0%
Q4 2019$10,756,000
+165.0%
15,230,000
+171.2%
0.00%0.0%
Q3 2019$4,059,000
+7.5%
5,615,0000.0%0.00%0.0%
Q2 2019$3,776,0005,615,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Cohanzick Management, LLC 25,112,000$25,557,98222.10%
Westchester Capital Management, LLC 8,267,000$8,308,5360.24%
MACQUARIE GROUP LTD 5,359,000$5,386,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders